MARKET

NAGE

NAGE

Niagen Bioscience, Inc
NASDAQ
3.230
+0.020
+0.62%
Pre Market: 3.290 +0.06 +1.86% 08:06 07/28 EDT
OPEN
3.250
PREV CLOSE
3.210
HIGH
3.310
LOW
3.200
VOLUME
2.03K
TURNOVER
0
52 WEEK HIGH
11.29
52 WEEK LOW
3.120
MARKET CAP
257.25M
P/E (TTM)
14.82
1D
5D
1M
3M
1Y
5Y
1D
Niagen Bioscience (NAGE) Gets a Buy from Roth MKM
TipRanks · 23h ago
Niagen Bioscience CEO to speak at Canaccord Genuity Growth Conference
PUBT · 1d ago
Weekly Report: what happened at NAGE last week (0720-0724)?
Weekly Report · 1d ago
Niagen Bioscience to Present at Canaccord Genuity’s 46th Annual Growth Conference
Barchart · 1d ago
Niagen Bioscience schedules Q2 earnings call after market close
PUBT · 07/21 12:32
Press Release: Niagen Bioscience to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
Dow Jones · 07/21 12:32
Niagen Bioscience price target lowered to $11 from $12 at Ladenburg
TipRanks · 07/21 12:00
Armata Pharmaceuticals (ARMP) Stock Jumps 12.2%: Will It Continue to Soar?
NASDAQ · 07/21 11:05
More
About NAGE
Niagen Bioscience, Inc. is a global bioscience company dedicated to promoting healthy aging. Its segments include Consumer Products, Ingredients segment, Analytical Reference Standards and Services and Pharmaceuticals. The Consumer Products segment provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors. The ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and outsourcing facilities. The Analytical Reference Standards and Services segment offer the supply of phytochemical reference standards and other research and development services. The Pharmaceutical segment focuses on the pharmaceutical development of its nicotinamide adenine dinucleotide (NAD) precursor portfolio for potential therapeutic applications in rare diseases.

Webull offers Niagen Bioscience Inc stock information, including NASDAQ: NAGE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NAGE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NAGE stock methods without spending real money on the virtual paper trading platform.